Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Senti Biosciences (SNTI) Revenue (2021 - 2023)

Senti Biosciences has reported Revenue over the past 3 years, most recently at $338000.0 for Q3 2023.

  • Quarterly results put Revenue at $338000.0 for Q3 2023, down 77.7% from a year ago — trailing twelve months through Jun 2024 was $338000.0 (down 90.47% YoY), and the annual figure for FY2025 was $22000.0, changed.
  • Revenue for Q3 2023 was $338000.0 at Senti Biosciences, down from $687000.0 in the prior quarter.
  • Over the last five years, Revenue for SNTI hit a ceiling of $1.5 million in Q3 2022 and a floor of $59000.0 in Q4 2022.
  • Median Revenue over the past 3 years was $852000.0 (2021), compared with a mean of $812500.0.
  • Peak annual rise in Revenue hit 63.71% in 2022, while the deepest fall reached 81.73% in 2022.
  • Senti Biosciences' Revenue stood at $323000.0 in 2021, then tumbled by 81.73% to $59000.0 in 2022, then soared by 472.88% to $338000.0 in 2023.
  • The last three reported values for Revenue were $338000.0 (Q3 2023), $687000.0 (Q2 2023), and $1.3 million (Q1 2023) per Business Quant data.